Global Investments In TB Control: Economic Benefits
- 1 January 2009
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 28 (Supplement), w730-w742
- https://doi.org/10.1377/hlthaff.28.4.w730
Abstract
The Global Plan to Stop TB calls for significant financial resources to meet the Millennium Development Goals for tuberculosis. However, it is unclear whether the economic benefits of TB control exceed the costs. Using an epidemiological model, we find that the economic benefits of the Global Plan relative to sustained DOTS (a commonly used treatment method) were unambiguously greater than the incremental costs in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Benefit-cost ratios of sustaining DOTS at current levels relative to having no DOTS exceeded 1 in all twenty-two high-burden, TB-endemic countries and sub-Saharan Africa.Keywords
This publication has 14 references indexed in Scilit:
- Introducing Incentives in the Market for Live and Cadaveric Organ DonationsJournal of Economic Perspectives, 2007
- The American Family and Family EconomicsJournal of Economic Perspectives, 2007
- The Value of Health and LongevityJournal of Political Economy, 2006
- Global epidemiology of tuberculosisThe Lancet, 2006
- TuberculosisThe Lancet, 2003
- Mortality decline, human capital investment, and economic growthJournal of Development Economics, 2000
- Prospects for worldwide tuberculosis control under the WHO DOTS strategyThe Lancet, 1998
- Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: An HIV Model, as an ExampleInternational Statistical Review / Revue Internationale de Statistique, 1994
- TuberculosisHealth Policy and Planning, 1991
- THE QUANTITY‐ADJUSTED VALUE OF LIFEEconomic Inquiry, 1988